78 related articles for article (PubMed ID: 33893844)
1. Tissue factor-bearing microparticles are a link between acute promyelocytic leukemia cells and coagulation activation: a human subject study.
Zhao H; Sun J; Yan L; Jin B; Hou W; Cao F; Li H; Zhou J; Zhang Y
Ann Hematol; 2021 Jun; 100(6):1473-1483. PubMed ID: 33893844
[TBL] [Abstract][Full Text] [Related]
2. Cellular microparticle and thrombogram phenotypes in the Prospective Observational Multicenter Major Trauma Transfusion (PROMMTT) study: correlation with coagulopathy.
Matijevic N; Wang YW; Wade CE; Holcomb JB; Cotton BA; Schreiber MA; Muskat P; Fox EE; Del Junco DJ; Cardenas JC; Rahbar MH; Cohen MJ;
Thromb Res; 2014 Sep; 134(3):652-8. PubMed ID: 25086657
[TBL] [Abstract][Full Text] [Related]
3. Measurement of microparticle tissue factor activity in clinical samples: A summary of two tissue factor-dependent FXa generation assays.
Hisada Y; Alexander W; Kasthuri R; Voorhees P; Mobarrez F; Taylor A; McNamara C; Wallen H; Witkowski M; Key NS; Rauch U; Mackman N
Thromb Res; 2016 Mar; 139():90-7. PubMed ID: 26916302
[TBL] [Abstract][Full Text] [Related]
4. Procoagulant microparticles promote coagulation in a factor XI-dependent manner in human endotoxemia.
Mooberry MJ; Bradford R; Hobl EL; Lin FC; Jilma B; Key NS
J Thromb Haemost; 2016 May; 14(5):1031-42. PubMed ID: 26857798
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with thrombo-hemorrhagic deaths in patients with Acute Promyelocytic leukemia treated with Arsenic Trioxide and all-trans retinoic acid.
Singh C; Karunakaran P; Yanamandra U; Jindal N; Kumar SR; Saini N; Jandial A; Jain A; Lad D; Prakash G; Khadwal A; Kumar N; Naseem S; Ahluwalia J; Varma N; Varma S; Malhotra P
Leuk Res; 2023 Nov; 134():107392. PubMed ID: 37774447
[TBL] [Abstract][Full Text] [Related]
6. Impact of Early Microparticle Release during Isolated Severe Traumatic Brain Injury: Correlation with Coagulopathy and Mortality.
Albert V; Subramanian A; Pati HP
Neurol India; 2024 Mar; 72(2):285-291. PubMed ID: 38691471
[TBL] [Abstract][Full Text] [Related]
7. Role of procoagulant microparticles in mediating complications and outcome of acute liver injury/acute liver failure.
Stravitz RT; Bowling R; Bradford RL; Key NS; Glover S; Thacker LR; Gabriel DA
Hepatology; 2013 Jul; 58(1):304-13. PubMed ID: 23389887
[TBL] [Abstract][Full Text] [Related]
8. Risk Markers for Significant Bleeding and Thrombosis in Pediatric Acute Promyelocytic Leukemia; Report From the Children's Oncology Group Study AAML0631.
Rajpurkar M; Alonzo TA; Wang YC; Gerbing RB; Gamis AS; Feusner JH; Gregory J; Kutny MA
J Pediatr Hematol Oncol; 2019 Jan; 41(1):51-55. PubMed ID: 30095694
[TBL] [Abstract][Full Text] [Related]
9. Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients.
Geddings JE; Mackman N
Blood; 2013 Sep; 122(11):1873-80. PubMed ID: 23798713
[TBL] [Abstract][Full Text] [Related]
10. Circulating Tissue Factor-Positive Procoagulant Microparticles in Patients with Type 1 Diabetes.
Zhang C; Ou Q; Gu Y; Cheng G; Du R; Yuan L; Cordiner RL; Kang D; Zhang J; Huang Q; Yu C; Kang L; Wang X; Sun X; Mo X; Tian H; Pearson ER; Meng W; Li S
Diabetes Metab Syndr Obes; 2019; 12():2819-2828. PubMed ID: 32021345
[TBL] [Abstract][Full Text] [Related]
11. Regulation of coagulation activation in newly diagnosed AML by the heme enzyme myeloperoxidase.
Langer F; Quick H; Beitzen-Heineke A; Janjetovic S; Mäder J; Lehr C; Bokemeyer C; Kuta P; Renné T; Fiedler W; Beckmann L; Klingler F; Rolling CC
Thromb Res; 2023 Sep; 229():155-163. PubMed ID: 37473552
[TBL] [Abstract][Full Text] [Related]
12. [Effects of Cytokines on Early Death in Patients with Newly Diagnosed Acute Promyelocytic Leukemia].
Zhao SX; Ge YY; Li ZZ; He HP; Shen CM; Shi KQ; Yang TH; DU YY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1315-1321. PubMed ID: 37846678
[TBL] [Abstract][Full Text] [Related]
13. Low platelet count is potentially the most important contributor to severe bleeding in patients newly diagnosed with acute promyelocytic leukemia.
Song YH; Peng P; Qiao C; Zhang R; Li JY; Lu H
Onco Targets Ther; 2017; 10():4917-4924. PubMed ID: 29062237
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers of bleeding and venous thromboembolism in patients with acute leukemia.
Hisada Y; Archibald SJ; Bansal K; Chen Y; Dai C; Dwarampudi S; Balas N; Hageman L; Key NS; Bhatia S; Bhatia R; Mackman N; Gangaraju R
J Thromb Haemost; 2024 Apr; ():. PubMed ID: 38574862
[TBL] [Abstract][Full Text] [Related]
15. Dysregulated hemostasis in acute promyelocytic leukemia.
Hisada Y
Int J Hematol; 2024 May; 119(5):526-531. PubMed ID: 38341391
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers of bleeding and venous thromboembolism in patients with acute leukemia.
Hisada Y; Archibald SJ; Bansal K; Chen Y; Dai C; Dwarampudi S; Balas N; Hageman L; Key NS; Bhatia S; Bhatia R; Mackman N; Gangaraju R
medRxiv; 2023 Oct; ():. PubMed ID: 37905148
[TBL] [Abstract][Full Text] [Related]
17. Tissue factor activates the coagulation cascade in mouse models of acute promyelocytic leukemia.
Hisada Y; Kawano T; Archibald SJ; Welch JS; Reeves BN; Mackman N
Blood Adv; 2023 Sep; 7(18):5458-5469. PubMed ID: 37450381
[TBL] [Abstract][Full Text] [Related]
18. Value of the FDP/FIB ratio in predicting early severe bleeding events in patients with newly diagnosed acute promyelocytic leukemia.
Li S; Gao Y; Li F; Zheng Y; Su Y
Ann Hematol; 2023 Apr; 102(4):787-794. PubMed ID: 36750485
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
